Volume 42, Number 6

Computational Discovery of Ketopioglitazone as a Potential PPAR-γ Agonist for Diabetes Management: Insights from Molecular Docking, Dynamics, and ADMET Analysis

Introduction Diabetes mellitus is a chronic metabolic disorder of millions [...]

By |2026-11-13T11:52:09+00:00November 13, 2026|Volume 42, Number 6|Comments Off on Computational Discovery of Ketopioglitazone as a Potential PPAR-γ Agonist for Diabetes Management: Insights from Molecular Docking, Dynamics, and ADMET Analysis
Go to Top